SLC6A4 and depressive symptom measurement: Together, these data suggest that increased pro-inflammatory LPS increases SERT activity to decrease serotonin and leads to depression behaviors that are mediated by several downstream signaling cascades, including IL-1 receptors and the MAPK pathway.